Dahlheim H, Thurnreiter M, Plaschke M, Durasin I, Reiter W, Rosenthal J
Department of Physiology, University of Munich, Federal Republic of Germany.
Kidney Int Suppl. 1990 Nov;30:S28-32.
The intention of this study was to characterize angiotensin I-forming angiotensinogenases (AIFAs) in rat extrarenal arterial walls and to clarify whether these enzymes are also present in the kidney. A further aim was to identify AIFAs in human vasculature and to establish whether they are affected in essential hypertension. Sprague-Dawley rats and vascular sections of patients undergoing corrective surgery were studied. Enzyme kinetic assays were performed using angiotensin I radioimmunoassay and purified natural angiotensinogens. Fast protein liquid chromatography was employed for biochemical characterization. A series of AIFAs with various isoelectric points, molecular weights and pH optima was detected in rat extrarenal vascular and, with differing distributions of enzyme activities, in renal tissues. In extrarenal arteries the main form of renal renin was present with a relatively low activity only. AIFAs were also demonstrable in human extrarenal vasculature and behaved like plasma renin in essential hypertension. The results indicate the existence of an intrinsic human vascular RAS in extrarenal (and renal) arteries. Extrarenal arterial AIFAs are not generally stimulated in essential hypertensives, as previously postulated.
本研究旨在表征大鼠肾外动脉壁中生成血管紧张素I的血管紧张素原酶(AIFAs),并阐明这些酶是否也存在于肾脏中。另一个目的是鉴定人类血管中的AIFAs,并确定它们在原发性高血压中是否受到影响。对Sprague-Dawley大鼠和接受矫正手术患者的血管切片进行了研究。使用血管紧张素I放射免疫测定法和纯化的天然血管紧张素原进行酶动力学测定。采用快速蛋白质液相色谱法进行生化表征。在大鼠肾外血管中检测到一系列具有不同等电点、分子量和最适pH值的AIFAs,在肾组织中也检测到酶活性分布不同的AIFAs。在肾外动脉中,肾素的主要形式仅以相对较低的活性存在。AIFAs在人类肾外血管中也可检测到,并且在原发性高血压中表现得与血浆肾素相似。结果表明在肾外(和肾)动脉中存在一种内在的人类血管肾素-血管紧张素系统(RAS)。如先前假设的那样,原发性高血压患者的肾外动脉AIFAs通常不会受到刺激。